Teva stock climbs past $30 with strong Austedo and Ajovy sales, but shifting Wall Street sentiment may affect its outlook.
Hello and welcome to another edition of Free Agent! It's still not too late to break out your ugly Christmas sweaters and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback